Scott Heyward, M.S.
At BioIVT, we understand the value of providing quality product. For over 30 years, BioIVT has been the market leader in hepatic products providing over a million vials worldwide of human hepatocytes to researchers. Prior to joining BioIVT, I worked for ten years at the Institute of Human Virology investigating acute HCV infection. We explored the immunological and virologic molecular response in the early stages of infection. We identified indicators that would lead to viral clearance or to persistent infection. It was through a collaboration with BioIVT to develop a primary hepatocyte infection models for HCV that I was introduced to the company and products. I eventually moved to BioIVT to continue working with hepatocytes but across broader applications that BioIVT serves.